Please login to the form below

Not currently logged in
Email:
Password:

Helen Parfitt joins Research Partnership

She takes on role as head of its Therapy Watch market tracking tool

Helen ParfittResearch Partnership has appointed Helen Parfitt as its new director, head of Therapy Watch - a ‘real-time’ syndicated global market tracking tool - in a role that will see her based at the firm’s head office in London.

Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director for M3 Group’s European division.

Her new role will see her join research directors Julia Godfrey and Laurent Chanroux in supporting the continued expansion of Therapy Watch, which currently runs global monitors in auto-immune, virology, oncology and nephrology.

She will also focus on the firm’s recently expanded oncology portfolio, which has added squamous cell carcinoma of the head and neck (SCCHN) and chronic myeloid leukaemia (CML) to its coverage.

Mark Jeffery, founding director of Research Partnership, said: “Helen brings with her a wealth of knowledge and expertise, her experience at GSK and Schering-Plough means she has also developed a strong understanding of clients’ needs.

“I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”

8th May 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....

Infographics